John W. Babich
President at Ratio Therapeutics, Inc.
Profile
John W.
Babich was the founder of Molecular Insight Pharmaceuticals, Inc. founded in 1997, where he held the position of Director, Chief Scientific Officer & EVP from 2009 to 2010.
Dr. Babich is also the founder of Noria Therapeutics, Inc. Dr. Babich's current job is President, Chief Scientific Officer & Director at Ratio Therapeutics, Inc. Dr. Babich's former job was Senior Vice President at Progenics Pharmaceuticals, Inc. Dr. Babich has a graduate degree from the University of Southern California, a doctorate degree from the University of London, and an undergraduate degree from St. John's University.
John W. Babich active positions
| Companies | Position | Start |
|---|---|---|
Ratio Therapeutics, Inc.
 Ratio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ratio Therapeutics, Inc. is a pharmaceutical company based in the United States. The company is based in Boston, MA. The company's mission is to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. The company's fully integrated proprietary R&D platforms, Trillium™ and Macropa™, enable the imaging, discovery, and advancement of novel radiopharmaceuticals that have first/best-in-class delivery, safety, and efficacy properties. Founded by John Babich, Ph.D., and Jack Hoppin, Ph.D., the company employs a growing team of radiopharmaceuticals discovery and development experts with backgrounds in the life science industry. The CEO of the company is Jack William Hoppin. | President | - |
Former positions of John W. Babich
| Companies | Position | End |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Noria Therapeutics, Inc.
 Noria Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, Noria Therapeutics, Inc. is a company that develops therapeutics. The company is based in New York, NY. The company was founded by John W. Babich. Noria Therapeutics was acquired by Bayer AG on June 03, 2021. | Founder | - |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Chief Executive Officer | - |
Training of John W. Babich
| University of Southern California | Graduate Degree |
| University of London | Doctorate Degree |
| St. John's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
Noria Therapeutics, Inc.
Noria Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, Noria Therapeutics, Inc. is a company that develops therapeutics. The company is based in New York, NY. The company was founded by John W. Babich. Noria Therapeutics was acquired by Bayer AG on June 03, 2021. | Commercial Services |
Ratio Therapeutics, Inc.
Ratio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ratio Therapeutics, Inc. is a pharmaceutical company based in the United States. The company is based in Boston, MA. The company's mission is to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. The company's fully integrated proprietary R&D platforms, Trillium™ and Macropa™, enable the imaging, discovery, and advancement of novel radiopharmaceuticals that have first/best-in-class delivery, safety, and efficacy properties. Founded by John Babich, Ph.D., and Jack Hoppin, Ph.D., the company employs a growing team of radiopharmaceuticals discovery and development experts with backgrounds in the life science industry. The CEO of the company is Jack William Hoppin. | Health Technology |
- Stock Market
- Insiders
- John W. Babich
